Confidence In SpringWorks Grows With Expanded GSK Deal And Nirogacestat Plans

On Track For First Approval In 2023

 
• By Andrew McConaghie
  
Multiple Myeloma Awareness: Bone marrow aspirate cytology of multiple myeloma, a type of bone marrow cancer of malignant plasma cells, associated with bone pain, bone fractures and anemia.
SpringWork's lead drug is being studied in combination with no fewer than seven BCMA-targeting agents in multiple myeloma. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Archive

More from Scrip